Product Information
SOLIFENACIN 5 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1413 per EA under NDC 00591379530. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on May 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591379530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SOLIFENACIN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA202551FDA Approved
5/20/2019
TE Code
AB
On Market Since
6/30/2020
Pharmacological Classes
Price Statistics
The NADAC for SOLIFENACIN 5 MG TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1413 per EA |
|---|---|
| All-time high | $0.2298 (Jun 14, 2023) |
| All-time low | $0.1413 (Sep 23, 2026) |
| 52-week high | $0.1863 |
| 52-week low | $0.1413 |
| Median price | $0.1827 |
| Average price | $0.1852 |
| Largest weekly change | -31.1% (Nov 20, 2024) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
solifenacin succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOLIFENACIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SOLIFENACIN 5 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1413 per EA (NDC 00591379530), effective Sep 30, 2026.
How has the price of SOLIFENACIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SOLIFENACIN 5 MG TABLET has declined 37.1%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for SOLIFENACIN 5 MG TABLET?
Since Feb 22, 2023, the NADAC for SOLIFENACIN 5 MG TABLET has ranged from a low of $0.1413 (Sep 23, 2026) to a high of $0.2298 (Jun 14, 2023), with a median of $0.1827 per EA.
Are there cheaper alternatives to SOLIFENACIN 5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SOLIFENACIN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SOLIFENACIN 5 MG TABLET?
SOLIFENACIN 5 MG TABLET (NDC 00591379530) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.